Mission
Board & Staff
Funding
Annual Reports
Contact Us
Editorials
Research Papers
Testimony
Letters
Media Coverage
Success Stories
Prevention
Indoor Residual Spraying
Insecticide-Treated Nets
Other Methods
Treatment
ACTs & Other Drugs
Malaria in Pregnancy
Co-Infection
Research
Insecticide Research
Drug Research
Vaccine Trials
Malarial Countries
Taxes & Tariffs
Regional Initiatives
Ministries of Health
Ministries of Finance
Donor Programs
Global Fund to Fight AIDS, TB & Malaria
Roll Back Malaria Partnership
World Health Organization
World Bank
UN Children's Fund
US Agency for International Development
Other Agencies
Private Sector
Companies, Foundations & PPPs
Non-Governmental Organizations
Commodities Manufacturers
Drug Safety
Public Health Insecticides
Campaigns
Become An Advocate
Press Releases
Events
Home
»
Browse content by issue
»
Malaria
»
Research
» Vaccine Trials
Vaccine Trials
Developing a vaccine against the complex
P. falciparum
parasite has proven extremely difficult. As such, experts estimate that an effective vaccine against malaria will not be available for at least another five years. If an effective vaccine is discovered, public health programs will inevitably face problems in deploying it. Antimalarial drugs and preventive tools will be needed for the foreseeable future, as will effective policies designed to ensure they reach those at risk of malaria.
The creation of the
Malaria Vaccine Initiative (MVI)
has enabled considerable progress towards finding an effective malaria vaccine. A recent vaccine candidate trial in Mozambique reduced childhood infection by a third and outbreaks of severe malaria by half. MVI in conjunction with GlaxoSmithKline and other partners is coordinating the next round of testing in Ghana.
For more information, please visit
MVI's website
.
Must Read
Malaria vaccine undergoes clinical trials in Tanzania
January 28, 2024
Potential Malaria vaccine gives hope in trial
January 24, 2024
Modified Mosquitoes May Be Anti-Malaria Allies
April 23, 2023
Ghana: Mal 47 Malaria Vaccine Trial - So Far So Good
December 14, 2023
Government-Controlled Research & Development - A Recipe for Disaster
May 22, 2023
AFM Articles
A long, hard road to the end of malaria in Africa
November 06, 2023
Vaccine Vacancy
October 15, 2023
News
At 50 percent efficacy the RTS,S malaria vaccine will not be a stand-alone solution
October 15, 2023
Malaria vaccine on the way
October 09, 2023
Aussie researchers 'close' to malaria vaccine
July 14, 2023
Malaria vaccine a letdown for infants
November 09, 2023
A Vaccine That Works Only Half the Time Is Not the Shot in the Arm Malaria Needs
October 24, 2023
» more...
Research
Malaria vaccine research and development: the role of the WHO MALVAC committee
October 11, 2023
Do we still need a malaria vaccine?
August 27, 2023
Malaria Eradication: Has the Time Come at Last?
October 29, 2023
Government-Controlled Research & Development - A Recipe for Disaster
May 22, 2023
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial
October 16, 2023
» more...
Press Releases
Uganda: First vaccination for GMZ2 malaria vaccine trial
May 09, 2023
Events
Fifth AMANET Biennial Conference
February 26, 2024
Back to Top